Skip to main content
Clinical Trials/NCT02826265
NCT02826265
Unknown
Not Applicable

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

Universitätsmedizin Mannheim1 site in 1 country100 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Universitätsmedizin Mannheim
Enrollment
100
Locations
1
Primary Endpoint
correlation of lung clearance index (LCI) as determined by multiple breath washout with emphysema quantification as determined by qCT
Last Updated
6 years ago

Overview

Brief Summary

Current diagnostic tools used in pulmonary disease often do not meet the challenges set by the respective pathophysiology. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various pulmonary diseases.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
December 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Frederik Trinkmann

Principal Investigator

Universitätsmedizin Mannheim

Eligibility Criteria

Inclusion Criteria

  • known or suspected pulmonary lung disease
  • indication for computed tomography

Exclusion Criteria

  • pregnancy
  • inability to participate

Outcomes

Primary Outcomes

correlation of lung clearance index (LCI) as determined by multiple breath washout with emphysema quantification as determined by qCT

Time Frame: 2 weeks

correlation of residual volume and airway resistance as determined by body plethysmography with and emphysema quantification as determined by qCT

Time Frame: 2 weeks

correlation of airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry with emphysema quantification as determined by qCT

Time Frame: 2 weeks

Study Sites (1)

Loading locations...

Similar Trials